Kumar Anand, Roberts Daniel, Wood Kenneth E, Light Bruce, Parrillo Joseph E, Sharma Satendra, Suppes Robert, Feinstein Daniel, Zanotti Sergio, Taiberg Leo, Gurka David, Kumar Aseem, Cheang Mary
Section of Critical Care Medicine, Health Sciences Centre/St. Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada.
Crit Care Med. 2006 Jun;34(6):1589-96. doi: 10.1097/01.CCM.0000217961.75225.E9.
To determine the prevalence and impact on mortality of delays in initiation of effective antimicrobial therapy from initial onset of recurrent/persistent hypotension of septic shock.
A retrospective cohort study performed between July 1989 and June 2004.
Fourteen intensive care units (four medical, four surgical, six mixed medical/surgical) and ten hospitals (four academic, six community) in Canada and the United States.
Medical records of 2,731 adult patients with septic shock.
None.
The main outcome measure was survival to hospital discharge. Among the 2,154 septic shock patients (78.9% total) who received effective antimicrobial therapy only after the onset of recurrent or persistent hypotension, a strong relationship between the delay in effective antimicrobial initiation and in-hospital mortality was noted (adjusted odds ratio 1.119 [per hour delay], 95% confidence interval 1.103-1.136, p<.0001). Administration of an antimicrobial effective for isolated or suspected pathogens within the first hour of documented hypotension was associated with a survival rate of 79.9%. Each hour of delay in antimicrobial administration over the ensuing 6 hrs was associated with an average decrease in survival of 7.6%. By the second hour after onset of persistent/recurrent hypotension, in-hospital mortality rate was significantly increased relative to receiving therapy within the first hour (odds ratio 1.67; 95% confidence interval, 1.12-2.48). In multivariate analysis (including Acute Physiology and Chronic Health Evaluation II score and therapeutic variables), time to initiation of effective antimicrobial therapy was the single strongest predictor of outcome. Median time to effective antimicrobial therapy was 6 hrs (25-75th percentile, 2.0-15.0 hrs).
Effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. Despite a progressive increase in mortality rate with increasing delays, only 50% of septic shock patients received effective antimicrobial therapy within 6 hrs of documented hypotension.
确定脓毒性休克反复/持续低血压初始发作后开始有效抗菌治疗延迟的发生率及其对死亡率的影响。
1989年7月至2004年6月进行的一项回顾性队列研究。
加拿大和美国的14个重症监护病房(4个内科、4个外科、6个内科/外科混合病房)和10家医院(4个学术性医院、6个社区医院)。
2731例成年脓毒性休克患者的病历。
无。
主要结局指标为出院存活情况。在2154例(占总数的78.9%)仅在反复或持续低血压发作后接受有效抗菌治疗的脓毒性休克患者中,有效抗菌治疗开始延迟与住院死亡率之间存在密切关系(校正比值比1.119[每延迟1小时],95%置信区间1.103 - 1.136,p<0.0001)。在记录到低血压的第一小时内给予对分离出或疑似病原体有效的抗菌药物,其生存率为79.9%。在随后6小时内抗菌药物给药每延迟1小时,生存率平均下降7.6%。持续性/反复性低血压发作后第二小时,相对于在第一小时内接受治疗,住院死亡率显著增加(比值比1.67;95%置信区间,1.12 - 2.48)。在多变量分析(包括急性生理与慢性健康状况评分II及治疗变量)中,开始有效抗菌治疗的时间是结局的唯一最强预测因素。有效抗菌治疗的中位时间为6小时(第25 - 75百分位数,2.0 - 15.0小时)。
在记录到低血压的第一小时内给予有效抗菌药物与成年脓毒性休克患者出院存活率增加相关。尽管随着延迟时间增加死亡率逐步上升,但仅有50%的脓毒性休克患者在记录到低血压的6小时内接受了有效抗菌治疗。